(Q68925766)
Statements
Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group (English)
D Menache
J P O'Malley
J B Schorr
B Wagner
C Williams
B M Alving
J O Ballard
S H Goodnight
W E Hathaway
1 January 1990